RU93032579A - METHOD OF TREATING AUTOIMMUNE DISEASES AND LEUKEMIA WITH AUTOIMMUNE MANIFESTATIONS - Google Patents

METHOD OF TREATING AUTOIMMUNE DISEASES AND LEUKEMIA WITH AUTOIMMUNE MANIFESTATIONS

Info

Publication number
RU93032579A
RU93032579A RU93032579/14A RU93032579A RU93032579A RU 93032579 A RU93032579 A RU 93032579A RU 93032579/14 A RU93032579/14 A RU 93032579/14A RU 93032579 A RU93032579 A RU 93032579A RU 93032579 A RU93032579 A RU 93032579A
Authority
RU
Russia
Prior art keywords
autoimmune
manifestations
leukemia
treating
autoimmune diseases
Prior art date
Application number
RU93032579/14A
Other languages
Russian (ru)
Other versions
RU2085215C1 (en
Inventor
В.С. Тер-Григоров
А.В. Пивник
О.Е. Ягужинская
З.Х. Мамиляева
О.Я. Московкина
В.А. Новиков
Original Assignee
Гематологический научный центр РАМН
Filing date
Publication date
Application filed by Гематологический научный центр РАМН filed Critical Гематологический научный центр РАМН
Priority to RU93032579A priority Critical patent/RU2085215C1/en
Priority claimed from RU93032579A external-priority patent/RU2085215C1/en
Publication of RU93032579A publication Critical patent/RU93032579A/en
Application granted granted Critical
Publication of RU2085215C1 publication Critical patent/RU2085215C1/en

Links

Claims (1)

Изобретение относится к медицине, в частности к иммунологическим методам лечения аутоиммунных заболеваний и лейкозов с аутоиммунными проявлениями. Способ основан на индукции синтеза антиидиотипических антиаутоиммунных антител в организме больного, что достигается с помощью иммунизации его соответствующими аутоантителами и рецепторами иммунных лимфоцитов, предварительно выделенными на иммуносорбентах, несущих антигены, служащие "мишенями" для аутоимунных реакций данного больного, и присоединенными к инертному носителю.The invention relates to medicine, in particular to immunological methods for the treatment of autoimmune diseases and leukemias with autoimmune manifestations. The method is based on the induction of the synthesis of anti-idiotypic anti-autoimmune antibodies in the patient's body, which is achieved by immunizing it with the appropriate autoantibodies and receptors of immune lymphocytes, previously isolated on immunosorbents carrying antigens, which serve as targets for the autoimmune reactions of the patient and attached to an inert carrier.
RU93032579A 1993-06-22 1993-06-22 Method of treatment of leukosis with autoimmune manifestation induced in experiment RU2085215C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU93032579A RU2085215C1 (en) 1993-06-22 1993-06-22 Method of treatment of leukosis with autoimmune manifestation induced in experiment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU93032579A RU2085215C1 (en) 1993-06-22 1993-06-22 Method of treatment of leukosis with autoimmune manifestation induced in experiment

Publications (2)

Publication Number Publication Date
RU93032579A true RU93032579A (en) 1996-06-10
RU2085215C1 RU2085215C1 (en) 1997-07-27

Family

ID=20143749

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93032579A RU2085215C1 (en) 1993-06-22 1993-06-22 Method of treatment of leukosis with autoimmune manifestation induced in experiment

Country Status (1)

Country Link
RU (1) RU2085215C1 (en)

Similar Documents

Publication Publication Date Title
AU2207788A (en) Tumor immunotherapy using anti-idiotypic antibodies
NO982062D0 (en) Humanized antibodies to human gp39, compositions containing them, and therapeutic use thereof
NL300353I1 (en) Drugs with monoclonal antibodies that are specific to the human epidermal growth factor receptor
MD1374G2 (en) Monoclonal immunostimulatin antibodies, method of obtaining thereof, cell lines, method of disease treatment and pharmaceutical composition
AU7519794A (en) Methods for b-cell population control
NZ508381A (en) Antibodies, antagonists and agonists of the death domain containing receptor 5 (DR5)
AU589351B2 (en) Tumor specific monoclonal antibodies
IL92037A0 (en) Novel family of high affinity,modified antibodies for cancer treatment
EP0674661A4 (en) Assay and treatment for demyelinating diseases such as multiple sclerosis.
ES8607024A1 (en) Monoclonal antibodies reactive with shared idiotypes on human antibodies to native DNA from patients with systemic Lupus erythematosus.
EP0194851A3 (en) Human tumor therapy
AU625171B2 (en) Specific excretion-secretion antigens of toxoplasma gondii, their expression products, processes for obtaining them and their diagnostic and prophylactic uses
RU93032579A (en) METHOD OF TREATING AUTOIMMUNE DISEASES AND LEUKEMIA WITH AUTOIMMUNE MANIFESTATIONS
EP0328578A4 (en) Antigen recognized by mca 16-88.
EP0537168A4 (en) Ctaa 28a32, the antigen recognized by mca 28a32
CA2038030A1 (en) Synthetic peptides which contain sequences from factor viia, and the use thereof
AU3283693A (en) Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy
EP0242154A3 (en) A novel tumor-associated antigen
EP0243058A3 (en) A novel tumor associated antigen
IL73281A0 (en) Purified antigen isolated from sera of leukemia and lymphoma patients,novel antibodies to said antigen,methods of preparing same and diagnostic and therapeutic methods employing said antibody
AU1508088A (en) Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
CA2151945A1 (en) Assay and treatment for demyelinating diseases such as multiple sclerosis